MANCHESTER, Conn., Oct. 19, 2016 -- Lydall, Inc. (NYSE:LDL) announced today that it will release its financial results for the third quarter ended September 30, 2016 on Tuesday, November 1, 2016 after the market closes. A conference call will be held on Wednesday, November 2, 2016 at 10:00 a.m. Eastern Time and be hosted by:
- Dale G. Barnhart, President and Chief Executive Officer;
- Scott M. Deakin, Executive Vice President and Chief Financial Officer; and
- David D. Glenn, Vice President, Corporate Development and Investor Relations.
Those interested may listen or participate in the conference call by calling 888-338-7142 or 412-902-4181, internationally. In addition, the audio of the call will be webcast live and will be available for replay at http://www.lydall.com in the Investor Relations Section.
A recording of the call will be available from 12:00 p.m. Eastern Time on November 2, 2016 through 11:59 p.m. Eastern Time on November 9, 2016 at 877-344-7529 or 412-317-0088, internationally; pass code 10094372.
Lydall, Inc. is a New York Stock Exchange listed company, headquartered in Manchester, Connecticut with global manufacturing operations producing specialty engineered products for the thermal/acoustical and filtration/separation markets. For more information, visit http://www.lydall.com. Lydall® is a registered trademark of Lydall, Inc. in the U.S. and other countries.
For further information contact: David D. Glenn Vice President, Corporate Development and Investor Relations Telephone 860-646-1233 Facsimile 860-646-8847 www.lydall.com [email protected]


Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Washington Post Publisher Will Lewis Steps Down After Layoffs
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 



